Immunome Inc 10-K for FY2023
Immunome Inc. (IMNM)
10-K
2024-03-28
For: 2023-12-31
View Original
Added on
April 12, 2026
About this 10-K
Immunome Inc filed this 10-K on March 28, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $14.02M
- Net loss
- $106.81M
- compared with a net loss of $36.9M a year earlier
- Diluted EPS
- -$5.38
- compared with -$3.09 a year earlier